Form 4 for VKTX Viking Therapeutics, Inc.
Accepted 2023-01-17 00:00:00 ET · period of report 2023-01-15 · accession 0001209191-23-003606 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-17 | 2023-01-15 | VKTX | Mancini Marianna | COO | F - Tax | $8.95 | -1,079 | 317.3K | -0.3% | -$9,657 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.00001 per share | 2023-01-15 | F | D | 1,079 | $8.95 | 317,273 | D | — | — |